The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain

Neuroscience

Volumn 73, Issue 2, 1996, Pages 429-447

  Rigby, M ^a   Le Bourdelles B ^a   Heavens, R P ^a   Kelly, S ^a   Smith, D ^a   Butler, A ^a   Hammans, R ^b   Hills, R ^b   Xuereb, J H ^a   Hill, R G ^a   Whiting, P J ^a   Sirina Thsinghji, D J S ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

human brain; in situ hybridization histochemistry; mRNA; NMDA receptor subunits

Indexed keywords

MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT;

ADULT; AGED; ARTICLE; BRAIN REGION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 20244375528     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00089-9     Document Type: Article

References (120)

1. Akazawa C., Shigemoto R., Bessho Y., Nakanishi S. and Mizuno N. (1994) Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. J. comp. Neurol. 347, 150-160.
2. Albin R. L., Aldridge J. W., Young A. B. and Gilman S. (1989) Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity. Brain Res. 491, 185-188.
3. Albin R. L. and Greenamyre J. T. (1992) Alternative excitotoxic hypothesis. Neurology 42, 733-738.
4. Albin R. L., Makowiec R. L., Hollingsworth Z. R., Dure L. S. IV, Penney J. B. and Young A. B. (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiography study. Neuroscience 46, 35-48.
5. Albin R. L., Reiner A., Anderson K. D., Penney J. B. and Young A. B. (1992) Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann. Neurol. 31, 425-430.
6. Albin R. L., Reiner A., Andersson K. D., Penney J. B. and Young A. B. (1990) Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann. Neurol. 27, 357-365.
7. Albin R. L., Young A. B. and Penney J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375.
8. Arai H., Kosaka K. and Jizuka R. (1984) Changes of biogenic amines and their metabolites in post-mortem brains from patients with Alzheimer-type dementia. J. Neurochem. 43, 388-393.
9. Aziz T. Z., Peggs D., Sambrook M. A. and Grossman A. R. (1991) Lesions of the subthalamic nucleus for alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism in the primate. Mov. Disord. 6, 288-292.
10. Beal M. F., Ferrante R. J., Swartz K. J. and Kowall N. W. (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11, 1649-1659.
11. Beal M. F., Kowall N. W., Ellison D. W., Mazurek M. F., Swartz K. J. and Martin J. B. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168-172.
12. Benes F. M. and Bird E. D. (1987) An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch. gen. Psychiat. 44, 608-616.
13. Benes F. M., Sorensen L., Vincent S. L., Bird E. D. and Sathi M. (1992) Increased density of glutamate-immuno-reactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb. Cortex 2, 503-512.
14. Bergman H., Wichmann T. and DeLong M. R. (1990) Reversal of experimental Parkinsonism by lesions of the subthalamic nucleus. Science 249, 1436-1438.
15. Bianchi A. L., Denavit-Saubé M. and Champagnat J. (1995) Central control of breathing in mammals: neuronal circuitry membrane properties and neurotransmitters. Physiol. Rev. 75, 1-45.
16. Bliss T. V. P. and Collingridge G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
17. Bogerts B., Lieberman J. A., Ashtari M., Bilder R. M., Degreef G., Lerner G., Johns C. and Masiar S. (1993) Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol. Psychiat. 33, 236-246.
18. Bondareff W., Mountjoy C. Q. and Roth M. (1982) Loss of neurons of the adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Neurology 32, 164-168.
19. Braak H. and Braak E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta neuropath. 82, 239-259.
20. Brotchie J. M., Mitchell I. J., Sambrook M. A. and Crossman A. R. (1991) Alleviation of Parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Mov. Disord. 6, 133-138.
21. Brown R., Colter N., Corsellis J. A., Crow T. J., Frith C. D., Jagoe R., Johnstone E. C. and Marsh L. (1986) Post mortem evidence of structural brain changes in schizophrenia. Differences in brain weight temporal horn area and parahippocampal gyrus compared with affective disorder. Arch. gen. Psychiat. 43, 36-42.
22. Cannon T. D. and Marco E. (1994) Structural brain abnormalities as indicators of vulnerability to schizophrenia. Schizophrenia Bull. 20, 89-103.
23. Carter C. J. (1982) Topographical distribution of possible glutamergic pathways from the frontal cortex to the striatum and substantia nigra in rats. Neuropharmacology 21, 379-383.
24. Chazot P. L., Coleman S. K., Cik M. and Stephenson F. A. (1994) Molecular characterisation of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J. biol. Chem. 269, 24402-24409.
25. Choi D. W. (1988) Glutamate neurotoxicity and diseases of the central nervous system. Neuron 1, 623-634.
26. Collingridge G. L. and Singer W. (1990) Excitatory amino acid receptors and synaptic plasticity. Trends pharmac. Sci. 11, 290-296.
27. Cotman C. W., Monaghan D. T., Ottersen O. P. and Storm-Mathisen J. (1987) Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci. 10, 273-280.
28. Cowburn R., Hardy J., Roberts P. and Briggs R. (1988) Presynaptic and postsynaptic glutamergic function in Alzheimer's disease. Neurosci. Lett. 86, 109-113.
29. Deakin J. F., Slater P., Simpson M. D., Gilchrist A. C., Skan W. J., Royston M. C., Reynolds G. P. and Cross A. J. (1989) Frontal cortical and left temporal glutamergic dysfunction in schizophrenia. J. Neurochem. 52, 1781-1786.
30. Dingledine R., McBain C. J. and McNamara J. O. (1991) Excitatory amino acids in epilepsy. In The Pharmacology of Excitatory Amino Acids (eds Lodge D. and Collingridge G.), Trends pharmac. Sci. Special Report (Elsevier Trends Journals), pp. 49-53.
31. Dupont J.-L., Gardette R. and Crepel F. (1987) Postnatal development of the chemosensitivity of rat cerebellar Parkinje cells to excitatory amino acids. An in vitro study. Devl Brain Res. 34, 59-68.
32. Erkinjuntti T., Lee D. H., Gao F., Steenhuis R., Eliasziw M., Fry R., Merskey H. and Hachinski V. C. (1993) Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol. 50, 305-310.
33. Ferrante R. J., Beal M. F., Kowall N. W., Richardson E. P. Jr and Martin J. B. (1987) Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res. 411, 162-166.
34. Ferrante R. J., Kowall N. W., Beal M. F., Martin J. B., Bird E. D. and Richardson E. P. Jr (1987) Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J. Neuropath. exp. Neurol. 46, 12-27.
35. Fonnum F. (1984) Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 42, 1-11.
36. Forrest D., Yuzaki M., Soares H. D., Ng L., Luk D. C., Sheng M., Stewart C. L., Morgan J. I., Connor J. A. and Curran T. (1994) Targeted disruption of NMDA receptor I gene abolishes NMDA response and results in neonatal death. Neuron 13, 325-338.
37. Francis P. T., Sims N. R., Procter A. W. and Bowen D. M. (1993) Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives. J. Neurochem. 60, 1589-1604.
38. Garthwaite G., Yamini B. and Garthwaite J. (1987) Selective loss of Purkinje and granule cell responsiveness to N-methyl-D-aspartate in rat cerebellum during development. Brain Res. 433, 288-292.
39. Geddes J. W., Chang-Chui H. C., Cooper S. M., Lott I. T. and Cotman C. W. (1986) Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease. Brain Res. 399, 155-161.
40. Getz C. (1991) The cerebellum. In Principles of Neural Science, 3rd edn (eds Kandel E. R., Schwartz J. H. and Jessel T. M.), pp. 626-646. Elsevier, New York.
41. Goodman C. S. and Shatz C. J. (1993) Developmental mechanisms that generate precise patterns of neuronal connectivity. Cell 72/Neuron 10 (Suppl.), 77-98.
42. Goodman C. S. and Shatz C. J. (1993) Developmental mechanisms that generate precise patterns of neuronal connectivity. Cell 72/Neuron 10 (Suppl.), 77-98.
43. Greenamyre J. T., Eller R. V., Zhang A., Ovadia A., Kurlan R. and Gash D. M. (1994) Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist in rodent and primate models of Parkinson's disease. Ann. Neurol. 35, 655-661.
44. Greenamyre J. T., Maragos W. J., Albin R. L., Penney J. B. and Young A. B. (1988) Glutamate transmission and toxicity in Alzheimer's disease. Proc. Neuro-psychopharmac. Biol. Psychiat. 12, 421-430.
45. 3H]glutamate binding. J. Neurochem. 48, 543-551.
46. Grillner S. and Shik M. L. (1973) On the descending control of the lumbosacral spinal cord from the 'mesencephalic locomotor region'. Acta physiol. scand. 87, 320-333.
47. Hall L. D., Herrod J. J., Carpenter T. A. and McKenna P. J. (1994) Magnetic resonance imaging in schizophrenia: a review of clinical and methodological issues. In Schizophrenia: Exploring the Spectrum of Psychosis (ed. Ancil R.). pp. 115-135. Wiley, New York.
48. Harrison P. J., McLaughlin D. and Kerwin R. W. (1991) Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 337, 450-452.
49. Hollmann M., Boulter J., Maron C., Beasley L., Sullivan J., Pecht G. and Heinemann S. (1993) Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron 5, 555-567.
50. Hyman B. T., Van Hoesen G. W., Damasio A. R. and Barnes C. L. (1984) Alzheimer's disease: cell-specific pathology isolates the hippocampus formation. Science 225, 1168-1170.
51. Hyman B. T., Van Hoesen G. W., Kromer L. J. and Damasio A. R. (1986) Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20, 472-481.
52. Ikeda K., Nagasawa M., Mori H., Araki K., Sakimura K., Watanabe M., Inoue Y. and Mishina M. (1992) Cloning and expression of the ε4 subunit of the NMDA receptor channel. Fedn Eur. biochem. Socs Lett. 313, 34-48.
53. Ishii T. (1966) Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta neuropath. 6, 181-187.
54. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M., Akazawa C., Shigemoto R., Mizuno J., Masu M. and Nakanishi S. (1993) Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J. biol. Chem. 268, 2836-2843.
55. Jobst K. A., Smith A. D., Szatmari M., Esiri M. M., Jaskowski A., Hindley N., McDonald B. and Molyneux A. J. (1994) Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet 343, 829-830.
56. Jobst K. A., Smith A., Szatmari M., Molyneux A., Esiri M. E., Smith A., Jaskowski A., McDonald B. and Wald N. (1992) Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 340, 1179-1183.
57. Johnson S. W., Seutin V. and North R. A. (1992) Burst firing in dopamine neurones induced by N-methyl-D-aspartate: role of the electrogenic sodium pump. Science 258, 665-667.
58. Kelly D. S. (1991) Sleep and dreaming. In Principles of Neural Science, 3rd edn (eds Kandel E. R., Schwartz J. H. and Jessel T. M.), p. 792-804. Elsevier, New York.
59. Kerwin R., Patel S. and Meldrum B. (1990) Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain postmortem. Neuroscience 39, 25-32.
60. Kim J. S., Hassler R., Hang P. and Paik K. S. (1977) Effect of frontal cortex ablation on striatal glutamic acid level in the rat. Brain Res. 132, 370-374.
61. Klockgether T., Kurski L., Honore T., Zhang Z., Gash D. M., Kurlan R. and Greenamyre J. H. (1991) The AMPA receptor antagonist NBQX has antiparkinsoniam effects in monoamine-depleted rats and MPTP-treated monkeys. Ann. Neurol. 30, 717-723.
62. Klockgether T. and Turski L. (1990) NMDA antagonists potentiate anti-parkinsonian actions of L-dopa in monoamine-depleted rats. Ann. Neurol. 28, 539-546.
63. Kovelman J. and Scheibel A. B. (1984) A neurohistological correlate of schizophrenia. Biol. Psychiat. 19, 1601-1621.
64. Krebs M. O., Desce J. M., Kernel M. L., Gauchy C., Godehen G., Cheramy A. and Glowinski J. (1991) Glutamergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56, 81-85.
65. Kudo N. and Yamada T. (1987) N-Methyl-D-aspartate-induced locomotor activity in a spinal cord-hindlimb muscles preparation of the newborn rat studied in vitro. Neurosci. Lett. 75, 43-48.
66. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K., Meguro H., Masaki H., Kumanishi T., Arakawa M. and Mishina M. (1992) Molecular diversity of the NMDA receptor channel. Nature 358, 36-41.
67. Laurie D. J. and Seeburg P. H. (1994) Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA. J. Neurosci. 14, 3180-3194.
68. Le Bourdelles B., Wafford K., Kemp J. A., Marshall G., Bain C., Wilcox A. S., Sikela J. M. and Whiting P. J. (1994) Cloning functional coexpression and pharmacological characterization of human cDNAs encoding NMDA receptor NR1 and NR2A subunits. J. Neurochem. 62, 2091-2098.
69. Lippa C. F., Hamos J. E., Pulaski-Salo D., Degennaro L. G. and Drachman D. A. (1992) Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol. Aging 13, 405-411.
70. Loughlin S. E. (1982) Locus coeruleus projections to the cortex: topography morphology and collateralization. Brain Res. Bull. 9, 287-294.
71. Mann D. M. A. (1983) The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mech. Ageing Dev. 23, 73-94.
72. Maragos W. F., Greenamyre J. T., Penney J. B. and Young A. B. (1987) Glutamate dysfunction in Alzheimer's disease: type. J. neurol. Sci. 49, 419-428.
73. Marcyniuk B., Mann D. M. A. and Yates P. O. (1986) Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged. Neurosci. Lett. 64, 247-252.
74. Martin J. H. (1989) Neuroanatomy: Text and Atlas. Elsevier, New York.
75. McBain C. J. and Mayer M. L. (1994) N-Methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 74, 723-760.
76. McDonald J. W. and Johnston M. V. (1990) Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15, 41-70.
77. McGeer P. L., McGeer E. G., Scherer U. and Singh K. (1977) A glutamergic corticostriatal path. Brain Res. 128, 369-373.
78. McIlhinney R. A. J., Molnar E., Atack J. R. and Whiting P. J. (1996) Cell surface expression of the human N-methyl-D-aspartate receptor subunit la (NR1a) requires the coexpression of the NR2A subunit in transfected cells. Neuroscience 70, 989-997.
79. Meguro H., Mori K., Araki E., Kushiya T., Kutsuwada M., Yamazaki T., Kumanishi M., Arakawa K., Sakimura K. and Mishina M. (1992) Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 357, 70-74.
80. Meldrum B. and Garthwaite J. (1990) Excitatory amino acid neurotoxicity and degenerative disease. Trends pharmac. Sci. 11, 379-387.
81. Mitani A., Andou Y. and Kataoka K. (1992) Selective vulnerability of hippocampal CA1 neurons cannot be explained in terms of an increase in glutamate concentration during ischaemia in the gerbil: brain microdialysis study. Neuroscience 48, 307-313.
82. Mitchell I. J., Clarke C. E., Boyce S., Robertson R. G., Peggs D., Sambrook M. A. and Crossman A. R. (1989) Neural mechanisms underlying Parkinsonian symptoms based on regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 32, 213-226.
83. Mitchell I. J., Lawson S., Moser B., Laidlaw S. M., Cooper A. J., Walkinshaw G. and Waters C. M. (1994) Glutamate-induced apoptosis results in a loss of striatal neurons in the Parkinsonian rat. Neuroscience 63, 1-5.
84. Monyer H., Burnashev N., Laurie D. J., Sakmann B. and Seeburg P. H. (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540.
85. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B. and Seeburg P. (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256, 1217-1221.
86. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N. and Nakanishi S. (1991) Molecular cloning and characterization of the rat NMDA receptor. Nature 354, 31-37.
87. Nakanishi S. (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258, 597-603.
88. Overton P. and Clark D. (1992) Electrophysiological evidence that intrastriatally administered N-methyl-D-aspartate augments striatal dopamine tone in the rat. J. Neural Trans. 4, 1-4.
89. Overton P. and Clark D. (1992) Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat. Synapse 10, 131-140.
90. Pearson R. C. A., Esiri M. M., Hiorns R. W., Wilcock G. K. and Powell T. P. S. (1985) Anatomical correlates of the pathological changes in the neocortex in Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 82, 4531-4534.
91. Petralia R. S., Yokotani M. and Wenthold R. J. (1994) Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J. Neurosci. 14, 667-696.
92. Pollard H., Khrestchatisky M., Moreau J. and Ben Ari Y. (1993) Transient expression of the NR2C subunit of the NMDA receptor in developing rat brain. NeuroReport 4, 411-414.
93. Reiner A., Albin R. I., Anderson K. D., D'Amato C. J., Penney J. B. and Young A. B. (1988) Differential loss of striatal projection neurons in Huntington disease. Proc. natn. Acad. Sci. U.S.A. 85, 5733-5737.
94. Robledo P. and Feger J. (1990) Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res. 518, 47-54.
95. Sakimura K., Kutsuwada T., Ito I., Manabe T., Takayama C., Kushiya E., Yagi T., Aizawa S., Inoue Y., Sugiyama H. and Mishina M. (1995) Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit. Nature 373, 151-154.
96. Satoh K., Tohyama M., Yamamoto T., Sakumoto T. and Shimizu N. (1977) Noradrenaline innervation of the spinal cord studied by horseradish peroxidase method combined with monoamine oxidase staining. Expl Brain Res. 223, 175-186.
97. Schwartz R., Hökfelt T., Fuxe K., Jonsson G., Goldstein M. and Terenius L. (1979) Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study. Expl Brain Res. 37, 199-216.
98. Sheng M., Cummings J., Roldan L. A., Jan Y. N. and Jan L. Y. (1994) Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368, 144-147.
99. Sherman A. D., Davidson A. T., Baruah S., Hegwood T. S. and Waziri R. (1991) Evidence of glutamergic deficiency in schizophrenia. Neurosci. Lett. 121, 77-80.
100. Sirinathsinghji D. J. S. and Dunnett S. B. (1993) Imaging gene expression in neural grafts. In Molecular Imaging in Neuroscience: A Practical Approach (ed. Sharif N. A.), pp. 43-70. Oxford University Press, Oxford.
101. Sirinathsinghji D. J. S., Rigby M., Heavens R. P., Smith D., Fernandez J. M., Schuligoi R. and Hill R. G. (1995) Increased messenger RNA expression of the 695 and 751 amino acid isoforms of the β-amyloid protein precursor in the thalamus of 17-year-old cynomolgus (Macaca fascicularis) monkeys. Neuroscience 65, 51-57.
102. Smith Y. and Parent A. (1988) Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res. 452, 353-356.
103. Standaert D. G., Testa C. M., Young A. B. and Penney J. B. Jr (1994) Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J. comp. Neurol. 343, 1-16.
104. Staubli U. (1992) A peculiar form of potentiation in mossy fibre synapses. Epilepsy Res. Suppl. 7, 151-157.
105. Sugihara H., Moriyoshi K., Ishii T., Masu M. and Nakanishi S. (1992) Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem. biophys. Res. Commun. 185, 826-832.
106. Tomlinson B. E., Irving D. and Blessed G. (1981) Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J. neurol. Sci. 49, 419-428.
107. Ulas J., Weihmuller F. B., Brunner L. C., Joyce J. N., Marshall J. F. and Cotman C. W. (1994) Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease Alzheimer's disease and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study. J. Neurosci. 14, 6317-6324.
108. Wafford K. A., Bain C. J., Le Bourdelles B., Whiting P. J. and Kemp J. (1993) Preferential co-assembly of recombinant NMDA receptors composed of three different subunits. NeuroReport 4, 1347-1349.
109. Wahlestedt C., Golanov E., Yamamoto S., Yee F., Ericson H., Yoo H., Inturissi C. E. and Reis D. J. (1993) Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363, 260-263.
110. Watanabe M., Inoue Y., Sakimura K. and Mishina M. (1992) Developmental changes in distribution of NMDA receptor channel subunit mRNAs. NeuroReport 3, 1138-1140.
111. Watanabe Y., Saito H. and Abe K. (1992) Effects of glycine and structurally related amino acids on generation of long-term potentiation in rat hippocampal slices. Eur. J. Pharmac. 223, 179-184.
112. Waterhouse B. D., Lin C-S., Burne R. D. and Woodward D. (1983) The distribution of neocortical projections neurones in the locus coeruleus. J. comp. Neurol. 217, 418-431.
113. West M. and Huang W. (1994) Spinal cord excitatory amino acids and cardiovascular autonomie responses. Ann. J. Physiol. 267, 865-873.
114. Whiting P. J. and Priestley T. (in press). The molecular biology of NMDA type glutamate receptors. In Amino Acid Neurotransmission (eds Turner A. J. and Stephenson F. A.). Portland Press.
115. Wullner U., Testa C. M., Catania M. V., Young A. B. and Penney J. B. (1994) Glutamate receptorsin striatum and substantia nigra: effects of medial forebrain bundle lesions. Brain Res. 645, 98-102.
116. Yamamoto T. and Hirano A. (1985) Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann. Neurol. 17, 573-577.
117. Yamazaki M., Mori M., Araki K., Mori K. J. and Mishina M. (1992) Cloning expression and modulation of a mouse NMDA receptor subunit. Fedn Eur. biochem. Socs Lett. 300, 39-45.
118. Yates C. M., Simpson J. and Gordon A. (1986) Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease. Neurosci. Lett. 65, 189-192.
119. 2+ influx in developing neocortex by excitatory and inhibitory neurotransmitters. Neuron 6, 333-344.
120. Zalutsky R. A. and Nicoll R. A. (1992) Mossy fibre long-term potentiation shows specificity but not apparent cooperativity. Neurosci. Lett. 138, 193-197.